The impact of the COVID-19 pandemic and the iPLEDGE risk evaluation and mitigation strategies update on isotretinoin prescription delays and interruptions: An interrupted time series analysis - 05/12/24
Doi : 10.1016/j.jaad.2024.10.077
Emma Beagles, BS a, b, Hye Jin Chung, MD, MMSc a, b, Allen F Shih, MD, MBA a, b, ⁎ 
a Department of Dermatology, Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
∗Correspondence to: Allen Shih, MD, MBA, Department of Dermatology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02115Department of DermatologyHarvard Medical SchoolBeth Israel Deaconess Medical Center330 Brookline AveBostonMA02115
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Thursday 05 December 2024
Key words : accutane, acne, COVID-19, FDA, health care disparities, health care policy, iPLEDGE, isotretinoin, medication access, pandemic, REMS, risk management, telehealth, time series
| Funding sources: This work was conducted with support from UM1TR004408 award through Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. |
|
| IRB approval status: The BIDMC Institutional Review Board reviewed and deemed this study exempt (IRB # 2023P000499). |
|
| Previous publications: None. |
© 2024
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.